Age and Testosterone Feedback Jointly Control the Dose-dependent Actions of Gonadotropin-releasing Hormone in Healthy Men
Overview
Affiliations
Healthy older men manifest combined declines in testosterone concentrations, LH secretory burst mass (amount of LH released per pulse), and feedback-sensitive regularity of unknown cause. To test a unifying hypothesis of simultaneous reductions in GnRH outflow, gonadotrope responsiveness to GnRH, and androgenic negative feedback, we monitored LH secretion 1) after bolus iv injection of a 1000-fold range of randomly ordered individual doses of GnRH on separate mornings, 2) during unmodified (eugonadal) or testosterone-withdrawn (hypoandrogenemic) negative feedback, and 3) in 16 young (age, 18-35 yr) and 15 older (age, 60-85 yr) healthy men. LH secretory burst mass and pattern regularity were quantitated by intensive blood sampling, high specificity LH beta-subunit-directed immunoradiometric assay, deconvolution analysis, and approximate entropy. GnRH dose responsiveness was assessed by four-parameter nonlinear regression analysis. We demonstrated that older men exhibit 1) delayed attainment of GnRH-evoked maximal LH secretion; 2) enhanced potency of GnRH stimulation in both the feedback-intact and feedback-withdrawn states; 3) elevated gonadotrope sensitivity to GnRH, unmasked by experimental testosterone depletion; 4) comparable young adult-like GnRH efficacy, independent of testosterone feedback milieu; and 5) diminished regularity of GnRH-induced LH release evident only during unmodified androgenic feedback. We conclude that a 3-fold interaction among GnRH dose, testosterone concentration, and age governs GnRH action, and age determines both testosterone-modulated and testosterone-independent actions of GnRH.
Aging and androgens: Physiology and clinical implications.
Anawalt B, Matsumoto A Rev Endocr Metab Disord. 2022; 23(6):1123-1137.
PMID: 36459352 PMC: 10370404. DOI: 10.1007/s11154-022-09765-2.
Roelfsema F, Liu P, Takahashi P, Yang R, Veldhuis J J Clin Endocrinol Metab. 2019; 105(3).
PMID: 31790144 PMC: 7025815. DOI: 10.1210/clinem/dgz246.
Nutsch V, Bell M, Will R, Yin W, Wolfe A, Gillette R Mol Cell Endocrinol. 2016; 442:153-164.
PMID: 28007657 PMC: 5276730. DOI: 10.1016/j.mce.2016.12.023.
Keenan D, Clarke I, Veldhuis J Endocrinology. 2011; 152(12):4882-93.
PMID: 22028450 PMC: 3230048. DOI: 10.1210/en.2011-1461.
Iranmanesh A, Mulligan T, Veldhuis J J Clin Endocrinol Metab. 2010; 95(6):2877-84.
PMID: 20357176 PMC: 2902075. DOI: 10.1210/jc.2009-2581.